Public policy study suggests two paths for a national pharmacare program, both with arm's length decision-making bodies
A study from the Institute for Research on Public Policy outlines two options considered constitutionally viable for a national pharmacare framework. Under the first, provincial governments would delegate the power to administer drug insurance plans